67 results
Page 2 of 4
424B3
o8wvkley6wjcc6cgy0u
16 Nov 22
Prospectus supplement
4:26pm
S-3
xumjr4jb750u3ny
4 Nov 22
Shelf registration
4:47pm
8-K
EX-99.1
nnh3y4093z84ute
3 Nov 22
Annexon Reports Third Quarter 2022 Financial Results and Plans to Provide Updates on Complement Therapeutic Portfolio in January 2023
6:45am
8-K
EX-99.1
w28t j7hr9pd6wj
8 Aug 22
Annexon Biosciences Highlights Business and Portfolio Progress and Key Anticipated Milestones and Reports Second Quarter 2022 Financial Results
4:30pm
8-K
EX-99.2
7xot7io80d8 uszo1h4f
8 Jul 22
Annexon Announces $130 Million Private Placement Financing
5:19pm
8-K
EX-10.1
2nrjqnjxf1ct
8 Jul 22
Annexon Announces $130 Million Private Placement Financing
5:19pm
8-K
EX-99.1
5van2
9 May 22
Annexon Biosciences Highlights Portfolio Progress and Key Anticipated Milestones, and Reports First Quarter 2022 Financial Results
4:20pm
POS AM
3j42hn077268ce4urrf
1 Mar 22
Prospectus update (post-effective amendment)
6:38pm
POSASR
incmtx16zo0b1qmhte
1 Mar 22
Automatic shelf registration (post-effective amendment)
4:01pm
8-K
EX-99.1
vy1d50a4jgfu 15f5gwq
10 Jan 22
Regulation FD Disclosure
6:40am
8-K
EX-99.1
9b5zi0pd
9 Nov 21
Annexon Biosciences Announces Business and Program Highlights and Reports Third Quarter 2021 Financial Results
4:16pm
S-3ASR
qxg6b qgu46oknzcmx
16 Aug 21
Automatic shelf registration
5:19pm